Kyly Clarke urges Aussies to step up to save lives from melanoma

Kyly Clarke urges Aussies to step up to save lives from melanoma

3 February 2020

Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.

Kyly toured Melanoma Institute Australia’s world-leading research and treatment centre where she met CEO Matthew Browne and Co-Medical Directors Professor Georgina Long and Professor Richard Scolyer. Kyly also met families devastated by melanoma, including Jen Benfield who has survived the disease, and the El-Hourani family, who sadly lost their mum and wife Kerry to melanoma.  

Kyly knows too well the personal impact of melanoma, with her own grandmother dying from the disease and herself having a melanoma scare.

‘I sadly never had the chance to meet my grandmother who died from melanoma before I was born,’ said Kyly. ‘Her death had such an impact on my family that I have always been extremely vigilant about checking my own skin for changes.

‘When I noticed one of my moles was changing, I sought medical advice and it was removed. Given my family history of melanoma, it was a tough week waiting for results to come back but luckily it was an abnormal mole rather than a melanoma.

‘I want my daughter Kelsey Lee to grow up in a world where sun safe behaviour is the norm and where there are effective treatments to save lives from melanoma, which is why I am delighted to be helping raise awareness and funds to help tackle this health issue facing all Australians,’ she said.

MIA CEO Matthew Browne said the organisation was excited to have Kyly supporting Melanoma March which raises awareness about melanoma prevention and early detection as well as money for life saving research to find new and effective treatments for the disease.

‘Clinical advances in recent years have tripled life expectancy for some advanced melanoma patients, but the sad reality is we still have one Australian dying every five hours from melanoma,’ Mr Browne said.

‘To reach our goal of zero deaths from melanoma we need to continue our research effort unabated and that is why Melanoma March is so important for all Australians to support.’

‘It may also come as a surprise to many that melanoma is the most common cancer affecting 15 to 39 year old Australians and that sunburn, particularly during childhood, is the greatest risk factor for developing melanoma,’ Mr Browne added. ‘We are so grateful for Kyly’s support in helping raise awareness amongst young Australians and young families that living a sun safe life NOW is vitally important.’

Australia has the highest melanoma rate in the world with one Australian diagnosed with the disease every half an hour. Early detection is vital, as 90% of melanomas can be cured with surgery alone if caught early.

‘Like all Australians, our family loves the great outdoors, but it is important we enjoy our beautiful climate safely to protect our skin from the damaging effects of the sun and reduce our risk of developing all skin cancers, including melanoma,’ Kyly said.

‘It is equally important that we are vigilant about checking our skin for changes, and if by sharing my story I can encourage just one family to be sun safe and to keep an eye on their skin, then I am helping make a difference.

‘I’d urge all families to join their local Melanoma March to help raise awareness as well as much-needed funds for research so that one day no one will die from melanoma.’

For more information on how to register for a march near you or donate to Melanoma March, click on link: Melanoma March.

 

Women of MIA lead the way in melanoma research at SMR
31 Oct 2018

Women of MIA lead the way in melanoma research at SMR

An impressive contingent of female delegates from Melanoma Institute Australia have presented findings across the whole spectrum of melanoma research at the Society for Melanoma Research 2018 Congress in Manchester, England.

Women of MIA lead the way in melanoma research at SMR
31 Oct 2018

Women of MIA lead the way in melanoma research at SMR - Copy

An impressive contingent of female delegates from Melanoma Institute Australia have presented findings across the whole spectrum of melanoma research at the Society for Melanoma Research 2018 Congress in Manchester, England.

Immune cell research presented at SMR
30 Oct 2018

Immune cell research presented at SMR

Over 800 researchers and clinicians from around the world were welcomed to Manchester for the 15th International Congress of the Society for Melanoma Research (SMR). Melanoma Institute Australia (MIA) has again sent an impressive number of delegates to present both oral presentations and posters with the latest in translational research.

Professor Georgina Long makes history as the first woman and first Australian to lead the Society for Melanoma Research
26 Oct 2018

Professor Georgina Long makes history as the first woman and first Australian to lead the Society for Melanoma Research

Professor Georgina Long makes history as the first woman and first Australian to lead the world’s most prestigious international melanoma research association.

Patients to benefit from updated skin tumour publications
26 Oct 2018

Patients to benefit from updated skin tumour publications

Two publications co-edited by MIA Co-Medical Director Professor Richard Scolyer are now available to healthcare professionals. They aim to provide assistance in the care and management of patients with skin cancer, including melanoma.

SunSafe Student Ambassador Program
25 Oct 2018

SunSafe Student Ambassador Program

Melanoma Institute Australia has introduced a new educational program to teach teenagers about the dangers of melanoma and the importance of sun safety. 

International collaboration the key to increasing survival
24 Oct 2018

International collaboration the key to increasing survival

"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.

High-risk Stage III melanoma patients to benefit from Australia/Netherlands collaboration
23 Oct 2018

High-risk Stage III melanoma patients to benefit from Australia/Netherlands collaboration

Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.

Monthly dose of immunotherapy allows flexibility for patients undergoing treatment
11 Oct 2018

Monthly dose of immunotherapy allows flexibility for patients undergoing treatment

A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.

Australia's best minds in melanoma research converge on Melbourne
08 Oct 2018

Australia's best minds in melanoma research converge on Melbourne

The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.

Nobel Prize for novel cancer therapies
04 Oct 2018

Nobel Prize for novel cancer therapies

The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.

World Health Organisation launches 4th edition of Classification of Skin Tumours
31 Aug 2018

World Health Organisation launches 4th edition of Classification of Skin Tumours

The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.

Professor John Thompson awarded prestigious 2018 RPA Foundation Research Medal
31 Aug 2018

Professor John Thompson awarded prestigious 2018 RPA Foundation Research Medal

Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.

Support PBS listing for pembrolizumab
23 Aug 2018

Support PBS listing for pembrolizumab

Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.

World Congress on Cancers of the Skin 2018
17 Aug 2018

World Congress on Cancers of the Skin 2018

The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.

Melanoma Institute Australia welcomes new CEO Matthew Browne
09 Aug 2018

Melanoma Institute Australia welcomes new CEO Matthew Browne

Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).

Melanoma in Practice: Nurse Conference
26 Jul 2018

Melanoma in Practice: Nurse Conference

It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’. 

Reducing the risk of melanoma in young adults
19 Jul 2018

Reducing the risk of melanoma in young adults

A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.

Melanoma Institute Australia launches free e-learning education portal
20 Jun 2018

Melanoma Institute Australia launches free e-learning education portal

Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.

David Day and a lifetime of missed moments
08 Jun 2018

David Day and a lifetime of missed moments

When David lost his life last year, he was 33, with three daughters under six.